@simonwhitemd

He/Him | PGY-2 @nyuuroresidency | @DukeU 2019 | @MedicineUVA 2024| Urologist in training

Joined August 2021
  • Tweets183
  • Following175
  • Followers180
4Media
Simon White, M.D. retweeted
Lee Zhao
@lee_c_zhaoOct 13
Stricture anatomy reads badly on a flat diagram, so I built one in 3D: a constructed 1.8 cm idiopathic bulbar stricture with five teaching overlays. Rotate it, open the cutaway, take the 60-second tour. leezhaomd.org/urethral-stric… Educational model, not medical advice. #Urology
Constructed bulbar stricture in cutaway, showing a narrowed channel and scar in the surrounding spongy tissue.

ALT Constructed bulbar stricture in cutaway, showing a narrowed channel and scar in the surrounding spongy tissue.

1
10
50
3,998
Simon White, M.D. retweeted
Lee Zhao
@lee_c_zhaoJun 22
Replying to @daviesbj
@daviesbj It’s not just urologic oncology. Interest in fellowship has shifted across urology. @societyGURS went from 29 fellows in 2006 to ~300 across 45 states by 2026. Every subspecialty has had some version of this expansion. Supply, demand, and a few things we do not say out loud. 🧵 fellowshiptree.leezhaomd.org
Benjamin J. Davies MD, MBA
@daviesbjJun 19
Why is there such diminished interest in urologic oncology with American residents? I need an explanation
4
22
4
101
30,081
Simon White, M.D. retweeted
Ashish M. Kamat, MD, MBBS
@UroDocAshMay 29
📐 HR 0.68 = a 32% relative risk reduction in recurrence at any given moment during follow-up. That sounds like a large benefit. But the absolute numbers tell a different story: BCG alone: 81.6% disease-free at 2 years BCG + durvalumab: 86.5% disease-free at 2 years Absolute difference: ~5% Since BCG already works well, a big relative reduction maps to a modest absolute gain. @MaxKates @UrogerliMD @JoshMeeks
2
10
1
37
3,298
Replying to @NYUUrology
@NYUUrology represents! Thank you to @NYSAUA for hosting the annual Valentine Essay Contest yesterday. Great catching up with friends and colleagues…
3
3
570
Congratulations to Samuel Carbunaru and Vyom Sawhney, our stellar NYU Langone residents, on your awards for original research presented at the @NYSAUA Valentine essay contest last night! 🎉👍🏅
5
11
1,096
Simon White, M.D. retweeted
Amr Elbakry@AmrElbakryUroMar 31
I’ve been trying maturing stoma first before ureter anastomosis for intracorporeal IC like I used to do in open. Easier to place diversion stents. Also no question about any potential tension on ureter anastomosis after maturing the stoma @lee_c_zhao @WVU_Urology @IFRUEUrol
1
6
1
56
3,998
Apply to our MATTER program which provides a $2k stipend for visiting sub-Is ⬇️ Visit for more information: pritzker.uchicago.edu/academ…
1
5
16
1,849
Simon White, M.D. retweeted
Andrea Apolo, M.D.@apolo_andreaFeb 27
The standard of care for MIBC will now include perioperative EVP for both cisplatin eligible and ineligible #BladderCancer pts. The EV304 study presented today @MattGalsky shows an improvement in EFS (HR 0.53) and OS (HR 0.65) for EVP over GC. @ASCO #GU26
2
97
4
198
11,957
Simon White, M.D. retweeted
Lee Zhao
@lee_c_zhaoFeb 23
In 1980, DeBakey operated on the Shah of Iran. He declares success. Soon, the patient is dead. Reoperation is psychologically brutal: how bias delay truth & what might save us from the same trap. leezhaomd.org/post/the-secon… #MedTwitter #Surgery #MedEd

The Second Cut: DeBakey, the Shah, and the Hubris of the Comforting Explanation | Lee C. Zhao, MD

1. The Legend, the King, and the Hostile Abdomen On March 28, 1980, in a military hospital on the banks of the Nile, Michael DeBakey removed a spleen the size

leezhaomd.org
16
58
15
218
94,659
Simon White, M.D. retweeted
NYU Urology Residency@NYUUROresidencyFeb 3
NYU Langone Urology is thrilled to welcome four new members to our team! Congratulations to all who matched successfully this year!
11
1
72
7,769
Simon White, M.D. retweeted
Jesse Persily@JPersily19 Jun 2025
Could not be more ecstatic to follow in the footsteps of some @NYUUrology giants and train at @UTSWUrology for @SUO_YUO fellowship. Beyond grateful for everyone who has helped along the journey! @KSMurrayUro @UroWCH @tanejauro @DrTanWP @wysock
5
8
66
4,395
Huge congrats to the bossman on receiving the 2025 Ferdinand C. Valentine Medal — a well-deserved honor for a true legend in the field. Proud to see him standing among giants (and holding his own). @NYSAUA @AmerUrological @nyugrossman @NYUUrology @nyulangone
3
14
1,543
Congratulations to Walter Roper for 1st place poster and Vyom Sawhney for 3rd place podium at the NY Section AUA Valentine Research contest! What a day for NYU Langone!
3
24
1,882
In the home stretch @NYUUrology with this crew! @NYSAUA
1
6
36
1,943
💫🌟New Review on Testicular Germ Cell Tumors! 🌟💫 @nirmishsingla @AdityaBagrodia  Dr #EzraBaraban @yalepathology @CDFankhauser @yasserged @JAMA_current @OncoAlert 💡 Key Insights: 🧬 Epidemiology & Risk Factors 🔹 Most common solid malignancy in men aged 15-40 🔹 ~10,000 cases annually in the U.S. 🔹 Risk factors: Cryptorchidism, family history, infertility, cannabis use, Klinefelter syndrome 🩺 Clinical Presentation & Diagnosis 🔹 Painless testicular mass is the most common symptom 🔹 Diagnosis: Scrotal ultrasound + tumor markers (AFP, β-hCG, LDH) 📊 Staging & Treatment 🔹 Stage I (70-75%): Orchiectomy + surveillance or adjuvant therapy 🏥 🔹 Stage II (20%): Lymph node involvement, treated with chemo, RPLND, or RT 🔹 Stage III (10%): Distant metastases → BEP/EP/VIP chemotherapy 💉 🎯 Survival & Long-term Effects 🔹 5-year survival rates: 99% (Stage I), 92% (Stage II), 85% (Stage III) 🔹 Long-term effects: Cardiovascular disease, secondary malignancies, infertility, hypogonadism, psychosocial impact 🧪 Emerging Biomarkers & Future Directions 🔹 miR-371a-3p: High sensitivity (91%) & specificity (94%) for early detection 🔹 Research is ongoing to refine risk stratification & de-escalate treatment @UCSD_Urology @UCSDCancer @UCSDHealth @DrRanaMcKay @MadamSurgeonMD @cjkane10 @endourologyucsd @JohnsHopkinsUni1 #OncoUrology #TesticularCancer #UroOncology #OncoTwitter #CancerResearch #MedicalOncology jamanetwork.com/journals/jam… – at Ciudad Autónoma de Buenos Aires, Argentina
1
76
1
161
16,905
Simon White, M.D. retweeted
UVA Surgery@UVASurgery5 Feb 2025
Happy to announce this collaboration between @UVASurgery and @uvaurology for qualified candidates. Let’s find a match @cmf2x @KGUROmd #urologymatch2025
23
68
9,537
Congratulations to these superstars 🌟! We are thrilled to welcome you to our NYU Langone Urology family!
3
20
4
122
14,903
Simon White, M.D. retweeted
UVA Urology@uvaurology29 Jan 2025
Attention med students‼️ We are offering a one-year paid research fellowship! This program is targeted towards 3rd & 4th year students or those who have recently gone unmatched in the Urology Match process. Click the link below for more details⬇️ med.virginia.edu/urology/edu…

William D. Steers Urology Research Fellowship - Department of Urology

med.virginia.edu
1
14
3
29
16,034
Simon White, M.D. retweeted
Samir Taneja@tanejauro8 Jan 2025
Looking for applicants interested in a one or two yr urologic oncology fellowship @NYUUrology. High volume of robotic surgery, PCa focal therapy, imaging, and multidisciplinary care. Formal research training/masters degree in the 2 yr model. If interested, DM me!
2
13
1
52
8,558
Simon White, M.D. retweeted
Urology Times
@UrologyTimes6 Jan 2025
Katie S. Murray, DO, (@KSMurrayUro) offers advice to urologists considering the adoption of newer treatment modalities for BCG-unresponsive NMIBC. @NYUUrology #blcsm urologytimes.com/view/bcg-un…

BCG-Unresponsive NMIBC: Insights for Newer Treatment Modalities | Urology Times

Katie S. Murray, DO, offers advice to urologists considering the adoption of newer treatment modalities for BCG-unresponsive non–muscle-invasive bladder cancer (NMIBC), encouraging them to integrate...

urologytimes.com
1
3
844
Load more